Complete pathologic response of HER2-positive breast cancer liver metastasis with dual anti-HER2 antagonism.

Schoellhammer, Hans F; Hsu, Felicia; Vito, Courtney; Chu, Peiguo; Park, Jinha; Waisman, James; Kim, Joseph

Schoellhammer, Hans F; Hsu, Felicia; Vito, Courtney; Chu, Peiguo; Park, Jinha; Waisman, James; Kim, Joseph.

Affiliation

Kim J; Division of Surgical Oncology, Department of Surgery, City of Hope Comprehensive Cancer Center, MD, 1500 E, Duarte Rd,, Duarte, CA 91010, USA. jokim@coh.org.

BMC Cancer ; 14: 242, 2014 Apr 04.

Article in En | MEDLINE | ID: mdl-24708527

Subject(s)

Antibodies, Monoclonal, Humanized/administration & dosage; Breast Neoplasms/drug therapy; Liver Neoplasms/drug therapy; Receptor, ErbB-2/genetics; Antineoplastic Combined Chemotherapy Protocols/administration & dosage; Breast Neoplasms/genetics; Breast Neoplasms/pathology; Clinical Trials as Topic; Female; Humans; Liver Neoplasms/pathology; Liver Neoplasms/secondary; Middle Aged; Molecular Targeted Therapy; Receptor, ErbB-2/antagonists & inhibitors; Trastuzumab

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Receptor, ErbB-2 / Antibodies, Monoclonal, Humanized / Liver Neoplasms Limits: Female / Humans / Middle aged Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2014 Type: Article

Fulltext

XML

PubMed Links

Search on Google